# KAN-004 for Immune-Related Diarrhea or Colitis

Source: https://onco.cc/trials/nct07196410/  
OnCo record `nct07196410` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of KAN-004 run by Centre hospitalier de l'Université de Montréal (CHUM), now recruiting.

## Summary

KAN-004 for Immune-Related Diarrhea or Colitis is a phase 1 interventional study registered as NCT07196410 by Centre hospitalier de l'Université de Montréal (CHUM), with 21 participants planned, started 2026-03-01. Conditions recorded: Colitis and Diarrhea Caused by Antitumor Drugs. Interventions recorded: KAN-004.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07196410
- Phase: 1
- Setting: A Phase I Study of KAN-004 in Patients With Immune-Related Diarrhea or Colitis
- Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
- Enrolled: 21

## Sources

- ClinicalTrials.gov NCT07196410: https://clinicaltrials.gov/study/NCT07196410

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [KAN-004](https://onco.cc/drugs/kan-004/)
- companies: [Kanvas Biosciences](https://onco.cc/companies/kanvas-biosciences/)

---
JSON: https://onco.cc/api/v1/entities/nct07196410.json